Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral administration formulation of blueberry extract as coadjuvant for preserving health of human precorneal film

A technology of blueberry extract and adjuvant, applied in the fields of medicine and ophthalmology, can solve problems such as no description

Inactive Publication Date: 2020-09-25
外科和医用视网膜中心
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of blueberry extracts in combination with lactoferrin and their combination with vitamin A, vitamin E and fish oils (eicosapentaenoic acid and docosahexaenoic acid) has not been previously described in the prior art. Formulations for oral administration in combination, nor their use as adjuvants for maintaining the health of the precorneal tear film

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] The present invention consists of blueberry (bilberry, Vaccinium myrtillus L) natural extract, pegylated recombinant human lactoferrin, fish oil (eicosapentaenoic acid and docosahexaene) for oral administration to adults acid), vitamin A and vitamin E formulations. The formulation has anti-inflammatory, antioxidant and neuroprotective properties. It also has antimicrobial properties, an essential element in the formation of the precorneal tear film component and an active agent with the ability to inhibit chronic inflammation of the ocular surface. The formulation has the potential to improve the health of the precorneal tear film by improving the secretion of the aqueous component of the precorneal tear film, increasing the breakup time of the precorneal tear film, modulating the inflammatory process present in the disease and promoting the preservation of the normal bacterial flora on the ocular surface potential role. The present invention is a nutraceutical formul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the health of the precorneal film and of the eye surface. The formulation contains an extract of natural origin (Vaccinium myrtillus L) with antioxidant and anti-inflammatory properties; it also uses eicosapentaenoic acid (EPA), omega-6, and docosahexaenoic acid (DHA), omega-3, obtained from fish oil and which, together with lactoferrin, vitamin A and vitamin E, improves tear quality, since these compounds have anti-microbial and anti-inflammatory effects. The formulation has been designed as a coadjuvant for preserving the health of the precorneal film. No formulation for oral administration of a blueberry extract together with lactoferrin, in combination with vitamin A, vitamin E and fish oil(eicosapentaenoic acid and docosahexaenoic acid) is found in the prior art, nor is the use of this formulation as an adjuvant for preserving the health of the precorneal film and / or the eye surface.

Description

technical field [0001] The present invention belongs to the field of medicine, in particular to the field of ophthalmology, in which it is the formulation of blueberry extract for oral administration to adults as an adjuvant for maintaining the health of the precorneal tear film. Background technique [0002] The surface of the eyeball and the various mechanisms that keep it in optimal condition are complex. Anatomically, the surface of the eye contains an epithelium of the mucosa between the upper and lower eyelids, in the interior between their edges. The primary function of the ocular surface is to provide clear vision while maintaining comfort and a suitable microbial flora. The ocular surface must be covered with a stable precorneal tear film over the atmospherically exposed ocular surface, as "Important concepts for treating eye surface and tear disorders," Am J Ophthalmol. 1997; 124:825-835. [0003] As outlined in "Important concepts for treating eye surface and te...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/07A61K36/45A61K31/201A61K31/202A61P27/02
CPCA61K31/07A61K31/202A61K36/45A61P27/02A61K38/40A61K31/355A61K2300/00A23L33/12A23L33/19A23L33/105A23L33/155
Inventor A·桑托斯加西亚J·C·阿尔塔米拉诺瓦莱霍J·A·查韦斯加西亚A·冈萨雷斯德拉罗萨
Owner 外科和医用视网膜中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products